The Ethics Working Group on Zika virus (ZIKV) Research and Pregnancy published an article in Vaccine last week. The article, titled “Ethics, Pregnancy, and ZIKV vaccine research and development” discusses the group’s ethics guidance as it applies to the on-going threat of ZIKV outbreaks.
KIE Research Associate Marisha Wickremsinhe presented at the Gender Justice Initiative’s Second Annual Faculty Research Colloquium October 13. She discussed research in pregnancy, including the ethics of risk/benefit trade offs between woman, fetus, and future child.
A report completed by Institute Director and Senior Research Scholar Maggie Little and colleagues was recently featured in Science as the leading guidance on the issue of maternal immunization ethics and the Zika virus.
Director and Senior Research Scholar Maggie Little, along with research team colleagues, will present selections from their work on the Zika virus at the upcoming meeting of the Consortium of Universities for Global Health.
Work by a research team headed by KIE Director Maggie Little focused on pregnancy health ethics was recently referenced in a paper highlighting prominent work on the issue.
KIE Director Maggie Little and colleagues comment on a recent article in JAMA Pediatrics they describe as unethically overstating the connection between of medication use during pregnancy and behavioral problems in childhood.
Dr. Maggie Little briefs a group at the US National Institutes of Health NIAID working to design a clinical development plan for testing a new malaria vaccine in pregnant women.
This week, the PHASES/Zika pregnancy ethics grant team heads to Buenos Aires for a series of international meetings and presentations.
Maggie Little was invited to brief Georgetown leadership on the Zika virus epidemic and her grant-funded work on the ethics of vaccination and treatment.
Dr. Maggie Little will travel with the PHASES/Zika pregnancy ethics grant team to Argentina in November to deliver the GFBR keynote address.